Tejkamal Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.50 Cr
- Company Age 17 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 18.84 Cr
- Revenue Growth 354.82%
- Profit Growth 101.94%
- Ebitda 97.68%
- Net Worth 0.48%
- Total Assets -18.55%
About Tejkamal Pharmaceuticals
Tejkamal Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2008 and has a history of 17 years. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.50 Cr.
The company has closed loans amounting to ₹18.84 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vipin Kumar and Deepa Jain serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231KA2008PTC045112
-
Company No.
045112
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jan 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Tejkamal Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Kumar
|
Director | 30-Jan-2008 | Current |
|
Deepa Jain
|
Director | 01-Feb-2021 | Current |
Financial Performance of Tejkamal Pharmaceuticals.
Tejkamal Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 354.82% increase. The company also saw a substantial improvement in profitability, with a 101.94% increase in profit. The company's net worth moved up by a moderate rise of 0.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tejkamal Pharmaceuticals?
In 2020, Tejkamal Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tejkamal Trade Links Private LimitedVipin Kumar and Deepa Jain are mutual person
-
Vertica Impex Private Limited
Vipin Kumar is a mutual person
-
Advanto Concepts Llp
Deepa Jain is a mutual person
Charges (Loans)
₹0
₹18.84 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 18.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2014 | Canara Bank | ₹0.75 M | Satisfied |
| 23 Oct 2013 | Canara Bank | ₹1.00 M | Satisfied |
| 02 Sep 2009 | Canara Bank | ₹18.66 Cr | Satisfied |
How Many Employees Work at Tejkamal Pharmaceuticals?
Unlock and access historical data on people associated with Tejkamal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tejkamal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tejkamal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
